3rd Antivirals Congress
12-14 October 2014 | NH Grand Krasnapolsky, Amsterdam, The Netherlands
What the delegates of the 2010 congress had to say...
“So much information in presentations in such a small period + good scheduling - no delays...”
“...atmosphere for discussions, relaxed and pleasant.”
“...a nice amount of collaborators around.”
“...the conference gave me a good opportunity to get into contact with many high ranking researchers in the field.”
“Good time-schedule, good meeting accommodations, good information desk.”
Speakers at the 2012 Conference
Raymond F. Schinazi, Emory University School of Medicine, USA
Patrick Kiser, University of Utah, USA
Jeffery K. Taubenberger, National Institutes of Health, USA
David R. Friend, CONRAD, USA
Teresa Compton, Biogen Idec, USA
Alan C. Jackson, University of Manitoba Health Sciences Centre, Canada
Subhash G. Vasudevan, Duke-NUS Graduate Medical School, Singapore (Co-Chair)
Julia Hilliard, Georgia State University, USA
Colleen B. Jonsson, Center for Predictive Medicine, USA
Sujan Shresta, La Jolla Institute for Allergy and Immunology, USA
Elena Govorkova, St. Jude Children’s Research Hospital, Memphis TN, USA
Warren Lee, University of Toronto, Canada
Ann Kwong, InnovaTID, USA
Fabien Zoulim, INSERM, France
Giorgio Palù, University of Padova, Italy
Scott Weaver, Galveston National Laboratory, USA
Kai Lin, Novartis, USA
Tomas Cihlar, Gilead Sciences, USA
Thomas Hope, Northwestern University, Chicago, USA
Eric Verdin, UCSF, USA
Gustavo Doncel, Eastern Virginia Medical School, USA
Yousuke Furuta, Toyama Chemical Company, Tokyo, Japan
2nd Antivirals Congress
11-13 November 2012 | Cambridge, MA, USA
Following the successful first Congress in Amsterdam, The Netherlands in 2010, the 2nd Antivirals Congress will be organized 11-13 November 2012 in Cambridge MA, USA. The key objectives of this interdisciplinary and unique congress are:
- To provide a state-of-the-art report for scientists, health professionals and (non)governmental authorities
- To accelerate progress in the development and application of antivirals: small molecules and biologics
- To serve as an interface between different interest groups from academia, those in research and development, regulatory and governmental agencies, charities, and health and industry professionals
The Congress will be supported by Antiviral Research, the most comprehensive and pre-eminent journal for those interested in the effective control of virus infections in animals and man as well as in plants or lower organisms.
Call for Papers
Present your latest research at this international forum for the exchange of new ideas on the development and application of antivirals. Abstracts for oral and poster presentations are invited by July 1, 2012 on the following topics:
|
|
- Access unique, high-quality content and gain a state-of-the-art report on the development of antivirals
- Learn from experts and opinion leaders in the field
- Present your research as an oral or poster presentation
- Network with an interdisciplinary group of scientists, officials, and practitioners in academia, industry, public health, and non-governmental and philanthropic institutions, among others
- Meet the Editors of the journal Antiviral Research
